Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products

NCT00515944 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Botulinum neurotoxin type A, free of complexing proteins

Sponsor

Merz Pharmaceuticals GmbH